20 Sept 2022

Fetch rewarding CPD and claim your Galliprant™ Power Pack

Just how common is canine OA in young dogs? Hear the surprising expert opinion on this hot topic and more.
Share on facebook
Share on linkedin
Share on twitter
Share on email
Share on print

The latest data on the prevalence of canine OA in young dogs has surprised even the experts. We explore this fascinating new data and more in five CPD video modules that you can watch at your own pace. Claim your free Galliprant Power Pack when you complete them!*

Get started now

What surprised Dr Duncan Lascelles the most?

Watch the preview to find out…

Hear what the experts think we can do about it:

Spotting OA in young dogs

OA in Young Dogs: More
Common Than You Might Think

Duration: 15 minutes

Dr Duncan Lascelles explores the prevalence of OA in young dogs and importance of early treatment.

Orthopaedic Evaluations – A Vet’s Perspective

Duration: 15 minutes

Dr Duncan Lascelles introduces two of the core components of orthopaedic examinations of dogs: observation and overall assessment.

Managing OA in young dogs

Making OA Consultations Easier

Duration: 10 minutes

Dr Zoe Belshaw discusses her approach to OA consults and pet owners education.

Galliprant: Protect the Moments That Matter

Duration: 15 minutes

Dr Lee Strapp introduces Galliprant, a piprant-class NSAID that gives you power over OA pain.^†

Real-Life Success Stories with Galliprant

Duration: 10 minutes

As part of the Galliprant in Practice Case Series, Dr Ciaran Jones shares two real-life success stories with Galliprant.

Start the CPD now

CPD, continuing professional development; NSAID, non-steroidal anti-inflammatory drug; OA, osteoarthritis.

* Terms and Conditions apply, see site for details.

^† Indication: Galliprant is indicated for treatment of pain associated with mild to moderate osteoarthritis in dogs.

Galliprant contains grapiprant. Legal category POM-V (UK) POM (IE). Further information is available from the Summary of Product Characteristics or datasheet. Advice should always be sought from the medicine prescriber. Information on this veterinary medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu. For further information, call Elanco Animal Health on +44 (0)1256 353131 or write to: Elanco UK AH limited, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA. Use medicines responsibly www.noah.co.uk/responsible (UK); www.apha.ie (IE).

Date of preparation: September 2022. PM-IE-22-0254